SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950168-02-002345
Filing Date
2002-08-14
Accepted
2002-08-14 10:36:12
Documents
9
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 PERIOD ENDING - 06/30/2002 d10q.txt 10-Q 56979
3 SEMI-EXCLUSIVE SUPPLY AGREEMENT dex1031.txt EX-10.31 46300
4 AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT dex1032.txt EX-10.32 154733
5 MARKETING LICENSE AGREEMENT dex1033.txt EX-10.33 63930
6 MASTER SERVICES AGREEMENT dex1034.txt EX-10.34 103618
7 STOCK PURCHASE AGREEMENT dex1035.txt EX-10.35 59147
8 INVESTMENT AND ROYALTY AGREEMENT dex1036a.txt EX-10.36A 58367
9 CERTIFICATION, FRED WILKINSON dex991.txt EX-99.1 1314
10 CERTIFICATION, DAVID L. WEINBERG dex992.txt EX-99.2 1323
  Complete submission text file 0000950168-02-002345.txt   548282
Mailing Address 100 NORTH VILLAGE AVENUE STE 32 ROCKVILLE CENTRE FL 11570
Business Address 100 NORTH VILLAGE AVENUE STE 32 ROCKVILLE CENTRE NY 11570 3059336089
COLUMBIA LABORATORIES INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 02732193
SIC: 2834 Pharmaceutical Preparations